Beranda › Kanker Kandung Kemih › Alabama › Birmingham
Uji klinis Kanker Kandung Kemih di Birmingham, AL
11 studi untuk Kanker Kandung Kemih mencari peserta di lokasi sekitar Birmingham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Menerima pesertaFase 3
- University of Alabama at Birmingham Cancer Center, Birmingham
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Menerima pesertaFase 2
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Menerima pesertaFase 2
- University of Alabama at Birmingham Cancer Center, Birmingham
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Menerima pesertaFase 1
- The Kirklin Clinic of UAB Hospital, Birmingham
- UAB Infusion Therapy Extended Care Clinic (ECC), Birmingham
- The University of Alabama at Birmingham Investigation Drug Services Pharmacy, Birmingham
- dan 1 lainnya
DESTINY-PANTUMOUR04
Menerima pesertaStudi observasional
- Research Site, Birmingham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Menerima pesertaStudi observasional
- University of Alabama at Birmingham, Birmingham
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Menerima pesertaFase 2
- Urology Centers of Alabama, Homewood · 3 mi jauhnya
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Menerima pesertaFase 1/2
- The University of Alabama at Birmingham Clinical Research Unit (CRU), Birmingham
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Menerima peserta
- Urology Centers of Alabama, Homewood · 3 mi jauhnya
Blue Light Cystoscopy With Cysview® Registry
Menerima pesertaStudi observasional
- The University of Alabama at Birmingham, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Birmingham
Uji klinis Kanker Kandung Kemih di kota lain
- New York City, NY35 studi
- Nashville, TN31 studi
- Houston, TX31 studi
- Dallas, TX27 studi
- Boston, MA26 studi
- Washington, DC26 studi
- Los Angeles, CA24 studi
- Baltimore, MD24 studi
- St. Louis, MO22 studi
- Philadelphia, PA21 studi
- Seattle, WA21 studi
- Edison, NJ21 studi
Studi lain di Birmingham
- Kanker (semua jenis)30 studi
- Kanker Payudara24 studi
- Obesitas23 studi
- Kanker Ovarium23 studi
- Kanker Paru Non-Sel Kecil22 studi
- Leukemia Mieloid Akut21 studi
- Mieloma Multipel18 studi
- PPOK17 studi
- Penyakit Kardiovaskular17 studi
- Kelebihan Berat Badan16 studi
- Kanker Endometrium16 studi
- Diabetes Tipe 216 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.